Oncology

Pharma News for Lexicon, Novartis, Takeda and HUTCHMED

Notizia - Recent Pharma, Healthcare and Biotech Happenings

FDA Approves Lexicon’s INPEFA (Sotagliflozin); PTC Therapeutics’s Vatiquinone MOVE-FA Registration-Directed Trial; EU Approval to Novartis’s Sickle Cell Disease Drug; EMA Approves Neoadjuvant Nivolumab/Chemotherapy in Resectable NSCLC; FDA Grants Priority Review to Fruquintinib for mCRC; FDA Orphan Drug Designation to Vega Therapeutics’s VGA039

Lexicon Announces FDA Approval of INPEFA (Sotagliflozin) For Treatment of Heart Failure Lexicon Pharmaceuticals, Inc. announced that the FDA has approved INPEFATM (sotagliflozin), a once-daily oral tablet, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes mellitus, chronic kidney disease, and other cardiovascular risk factors. The broad label includes heart failure patients with any level of left ventricular ejection fraction (LVEF), including preserved and diminished ejection fraction, as well as patients with or without diabetes. "The approval of INPEFA...

Explore More...

Analyzing the Key Trends Driving the Biosimilar Market Growth

pharma-news-for-edwards-lineage-novartis-koios-medical

Edwards’ Sapien 3 with Alterra Prestent; Koios Medical’s breast, thyroid cancer-spotting AI; Lineage Collaborates with Genentech; Novartis, BeiGene ink deal

Insights into some of the Biosimilar Drugs that are approved and launched in 2021

pharma-news-for-pfizer-takeda-novartis-roche

Pfizer to acquire Arena Pharma; Takeda’s ‘Wave 2’ multiple myeloma med data; Novartis’s next-gen CAR-Ts clinical data; Roche unveils Avenio system

car-t-cell-therapy-market-competitive-landscape-key-players

CAR-T Cell Therapy aka Miraculous Technology: Mapping the Market, Approved Therapies, Competitive Landscape and Impact of COVID-19

Major Highlights of ASH 2021 Annual Meeting: Stay abreast of the fresh developments!!

medtech-news-for-boston-scientific-bd-roche-linus-helioliver

Boston Scientific’s MODULAR CRM System; Restore Medical’s ContraBand clinical trial result; BD acquires Venclose; Roche differentiates mutations in Omicron; Linus’s StrandDx-ASD; HelioLiver launches liquid biopsy test

pharma-news-for-aslan-iqvia-reata-recordati-eusa

Aslan Pharma – IQVIA collaboration; Reata’s kidney drug bardoxolone; Alzheimer’s Disease treatment update; Recordati to acquire EUSA

T-cell Immunoglobulin and ITIM domain (TIGIT) Inhibitor: An Insight into the Pipeline Development Activities, Major Collaborations, and Advancements

Analyzing the Growth of the Biosimilar Market Through Years

pharma-news-for-ge-optellum-therapixel-ocugen-blueprint

GE Healthcare-Optellum’s collaboration; Ocugen’s Covid-19 vaccine trial; Blueprint to acquire Lengo Therapeutics; Therapixel’s Mammoscreen

Diverse Pipeline Therapies to Glide the Follicular Lymphoma Treatment Market

pharma-news-for-astrazeneca-wision-getinge-lumithera

AstraZeneca-Moderna’s AZD8601 VEGF-A mRNA Trial; Wision AI gets CE Mark approval; Getinge acquires Verrix; LumiThera buys Diopsys

pharma-happenings-for-alcon-philips-bioxcel-penumbra

Alcon to acquire Ivantis; Philips to takeover Cardiologs; Flunked cancer drug progresses in I-O in pancreatic cancer models; Indigo system CAT RX catheter meets primary endpoint in trial

An in-depth Assessment of the Top Drugs Launched by Leading Global Companies in the First Half of 2021 (H1)

recent-pharma-news-for-roche-blue-wolf-capital-click-therapeutics

Ocular Therapeutix’s insert fails in phase 2; Click Therapeutics raises $52M funding; Roche introduces AVENIO Tumour Tissue CGP Kit; Blue Wolf Capital to acquire CIVCO Radiotherapy

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective